{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:07:45Z","timestamp":1773965265743,"version":"3.50.1"},"reference-count":19,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dan Med J"],"abstract":"<jats:p>INTRODUCTION. A no-biopsy approach has been suggested for diagnosing coeliac disease (CD) in adult patients. This approach is already well established in diagnosing children with CD. This study aimed to evaluate the accuracy of IgA anti-tissue transglutaminase (IgA anti-tTG) in predicting duodenal mucosal lesions diagnostic of CD in adult patients.\n\nMETHODS. We included all patients aged \u2265 18 years referred for CD diagnostics at our department in the period from 1 January 2019 to 31 December 2023 with raised IgA anti-tTG levels and in whom duodenal biopsies had been evaluated for CD-specific lesions. Data regarding IgA anti-tTG levels and duodenal histology evaluated by the modified Marsh classification were retrieved from the patient records.\n\nRESULTS. A total of 235 adult patients had positive IgA anti-tTG levels and an available duodenal histology. High IgA anti-tTG levels (&gt; 10 \u00d7 upper limit of normal (ULN)) were associated with more severe enteropathy. The PPV of IgA anti-tTG for identifying Marsh \u2265 2 or 3 lesions increased when the serological cut-off was raised. The positive predictive value of IgA anti-tTG &gt; 10 \u00d7 ULN was 99.2% (95% CI: 95.8-100%) and 97.7% (95% CI: 93.4-99.5%) for predicting Marsh \u2265 2 and 3 lesions, respectively.\n\nCONCLUSIONS. This study confirms that high titers of IgA anti-tTG may accurately identify adults with diagnostic duodenal mucosal lesions associated with CD. Our data support the use of a no-biopsy approach for diagnosing CD in adults with high IgA anti-tTG titers.\n\nFUNDING. None.\n\nTRIAL REGISTRATION. Not relevant.<\/jats:p>","DOI":"10.61409\/a03250187","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:32:36Z","timestamp":1756902756000},"page":"1-9","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic accuracy of IgA anti-tissue transglutaminase for the diagnosis of coeliac disease"],"prefix":"10.61409","author":[{"given":"Maria Nyholm","family":"Iversen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrine","family":"Stribolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Lodberg","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Dige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,8]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Catassi C, Verdu EF, Bai JC, Lionetti E. Coeliac disease. Lancet. 2022;399(10344):2413-2426. https:\/\/doi.org\/10.1016\/S0140-6736(22)00794-2","DOI":"10.1016\/S0140-6736(22)00794-2"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63(8):1210-1228. https:\/\/doi.org\/10.1136\/gutjnl-2013-306578","DOI":"10.1136\/gutjnl-2013-306578"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Rubio-Tapia A, Hill ID, Semrad C, et al. American College of Gastroenterology guidelines update: diagnosis and management of celiac disease. Am J Gastroenterol. 2023;118(1):59-76. https:\/\/doi.org\/10.14309\/ajg.0000000000002075","DOI":"10.14309\/ajg.0000000000002075"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Picarelli A, Borghini R, Donato G, et al. Weaknesses of histological analysis in celiac disease diagnosis: new possible scenarios. Scand J Gastroenterol. 2014;49(11):1318-1324. https:\/\/doi.org\/10.3109\/00365521.2014.948052","DOI":"10.3109\/00365521.2014.948052"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Shiha MG, Nandi N, Raju SA, et al. Accuracy of the no-biopsy approach for the diagnosis of celiac disease in adults: a systematic review and meta-analysis. Gastroenterology. 2024;166(4):620-630. https:\/\/doi.org\/10.1053\/j.gastro.2023.12.023","DOI":"10.1053\/j.gastro.2023.12.023"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Ciacci C, Bai JC, Holmes G, et al. Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study. Lancet Gastroenterol Hepatol. 2023;8(11):1005-1014. https:\/\/doi.org\/10.1016\/S2468-1253(23)00205-4","DOI":"10.1016\/S2468-1253(23)00205-4"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Erikstrup C, Sorensen E, Nielsen KR, et al. Cohort profile: The Danish blood donor study. Int J Epidemiol. 2023;52(3):e162-e171. https:\/\/doi.org\/10.1093\/ije\/dyac194","DOI":"10.1093\/ije\/dyac194"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11(10):1185-1194. https:\/\/doi.org\/10.1097\/00042737-199910000-00019","DOI":"10.1097\/00042737-199910000-00019"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Penny HA, Raju SA, Lau MS, et al. Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts. Gut. 2021;70(5):876-883. https:\/\/doi.org\/10.1136\/gutjnl-2020-320913","DOI":"10.1136\/gutjnl-2020-320913"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Hoyle A, Gillett P, Gillett HR, et al. No-biopsy strategy for coeliac disease is applicable in adult patients: a 'real-world' Scottish experience. Frontline Gastroenterol. 2023;14(2):97-102. https:\/\/doi.org\/10.1136\/flgastro-2022-102254","DOI":"10.1136\/flgastro-2022-102254"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Holmes GKT, Forsyth JM, Knowles S, et al. Coeliac disease: further evidence that biopsy is not always necessary for diagnosis. Eur J Gastroenterol Hepatol. 2017;29(6):640-645. https:\/\/doi.org\/10.1097\/MEG.0000000000000841","DOI":"10.1097\/MEG.0000000000000841"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Zanini B, Magni A, Caselani F, et al. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Dig Liver Dis. 2012;44(4):280-285. https:\/\/doi.org\/10.1016\/j.dld.2011.10.013","DOI":"10.1016\/j.dld.2011.10.013"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Beltran L, Koenig M, Egner W, et al. High-titre circulating tissue transglutaminase-2 antibodies predict small bowel villous atrophy, but decision cut-off limits must be locally validated. Clin Exp Immunol. 2014;176(2):190-198. https:\/\/doi.org\/10.1111\/cei.12249","DOI":"10.1111\/cei.12249"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Fuchs V, Kurppa K, Huhtala H, et al. Serology-based criteria for adult coeliac disease have excellent accuracy across the range of pre-test probabilities. Aliment Pharmacol Ther. 2019;49(3):277-284. https:\/\/doi.org\/10.1111\/apt.15109","DOI":"10.1111\/apt.15109"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Sch\u00f8sler L, Christensen LA, Hvas CL. Symptoms and findings in adult-onset celiac disease in a historical Danish patient cohort. Scand J Gastroenterol. 2016;51(3):288-294. https:\/\/doi.org\/10.3109\/00365521.2015.1092576","DOI":"10.3109\/00365521.2015.1092576"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Efthymakis K, Serio M, Milano A, et al. Application of the biopsy-sparing ESPGHAN guidelines for celiac disease diagnosis in adults: a real-life study. Dig Dis Sci. 2017;62(9):2433-2439. https:\/\/doi.org\/10.1007\/s10620-017-4672-1","DOI":"10.1007\/s10620-017-4672-1"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Corazza GR, Villanacci V, Zambelli C, et al. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol. 2007;5(7):838-843. https:\/\/doi.org\/10.1016\/j.cgh.2007.03.019","DOI":"10.1016\/j.cgh.2007.03.019"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Stefanolo JP, Zingone F, Gizzi C, et al. Upper gastrointestinal endoscopic findings in celiac disease at diagnosis: a multicenter international retrospective study. World J Gastroenterol. 2022;28(43):6157-6167. https:\/\/doi.org\/10.3748\/wjg.v28.i43.6157","DOI":"10.3748\/wjg.v28.i43.6157"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Shiha MG, Nandi N, Hutchinson AJ, et al. Cost-benefits and environmental impact of the no-biopsy approach for the diagnosis of coeliac disease in adults. Frontline Gastroenterol. 2023;15(2):95-98. https:\/\/doi.org\/10.1136\/flgastro-2023-102494","DOI":"10.1136\/flgastro-2023-102494"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:35:41Z","timestamp":1761129341000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A03250187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.61409\/a03250187","relation":{},"ISSN":["2245-1919"],"issn-type":[{"value":"2245-1919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}